The devicemaker’s March 26 filing revealed the compensation packages for five executives from 2021 to 2023. Compensation packages include salary, stock and option awards, non-equity incentive plan compensation, and other pay.
Here’s what each executive made during that time:
Kevin Lobo, CEO
2023: $20.8 million
2022: $18.6 million
2021: $16.4 million
Glenn Boehnlein, vice president and CFO
2023: $6.8 million
2022: $5.9 million
2021: $6 million
J. Andrew Pierce, group president of neurotechnology
2023: $6.5 million
2022: $5.7 million
2021: $5.3 million
Spencer Stiles, group president of orthopedics and spine
2023: $6.5 million
2022: $5.7 million
2021: $5.2 million
Viju Menon, group president of global quality and operations
2023: $4.5 million
2022: $3.7 million
2021: $4.3 million
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
